2024
16 Sep
CARMIEL, Israel, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Protalix BioTherapeutics, Inc. (NYSE American:PLX), a
2024
04 Sep
CARMIEL, Israel , Sept. 4, 2024 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX),
2024
03 Sep
Company is debt-free with no outstanding notes Balance sheet provides sufficient runway for ongoing operations